spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  D-SPECT 

 HSMN NewsFeed - 20 Aug 2024
RYBREVANT(R) (amivantamab-vmjw) Plus LAZCLUZE(TM) (lazertinib) Approved in the U.S. as a First-line Chemotherapy-free Treatment for Patients with EGFR-mutated Advanced Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Jul 2023
Boehringer Ingelheim Receives FDA Approval for NexGard(R) PLUS (afoxolaner, moxidectin and pyrantel chewable tablets): A Beef-Flavored Soft Chew That Protects Dogs from Internal and External Parasites
Biopharmaceuticals Veterinary FDA
 HSMN NewsFeed - 18 Jan 2022
Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 16 Nov 2021
Sonendo Announces Alma Salazar as Associate Vice President, Professional and Consumer Marketing
Devices Dental Personnel
 HSMN NewsFeed - 25 May 2021
BD Launches Industry First Ready-to-Use Iodine-Based Surgical Irrigation System
Devices Product Launch
 HSMN NewsFeed - 17 Dec 2020
Leading BioSciences and Seneca Biopharma Announce Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Jun 2020
Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2020
Sciton Unveils Newest Aesthetic Platform, mJOULE(TM) Featuring BBL HERO(TM) And MOXI(TM)
Devices Dermatology Product Launch
 HSMN NewsFeed - 19 May 2020
Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Mar 2020
SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Jan 2020
Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2019
Microbion Corporation Announces Generic Name for Lead Antimicrobial Compound: Pravibismane
Biopharmaceuticals Generics
 HSMN NewsFeed - 11 Oct 2019
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2019
PolyPid Announces Completion of $50 Million Series E-1 Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jul 2019
Aridis Pharmaceuticals Enters Into Equity Purchase and Option Agreements with The Serum Institute of India, Ltd for Exclusive License to Products and MabIgX(R) Platform Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Jul 2019
Aridis Pharmaceuticals Receives Orphan Drug Designation From the European Medicines Agency for AR-501
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Jun 2019
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2019
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Feb 2019
NW Bio Hires David Innes As Vice President, Investor Relations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Feb 2019
FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Nov 2018
OsteoRemedies(R) Announces the First FDA Cleared Dual-Antibiotic Spacer and Bone Cement with Gentamicin and Vancomycin
Devices Orthopaedic FDA Product Launch
 HSMN NewsFeed - 20 Aug 2018
Boehringer Ingelheim Announces The Launch Of CENTRAGARD(TM) (eprinomectin and praziquantel transdermal solution), Innovative Internal Parasite Protection For Cats
Biopharmaceuticals Veterinary Product Launch
 HSMN NewsFeed - 7 Jun 2018
SutroVax Announces $85M Series C Financing led by TPG Growth
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 19 Mar 2018
Amplyx Pharmaceuticals Receives Fourth "Qualified Infectious Disease Product" (QIDP) Designation from the FDA for APX001
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Mar 2018
Organogenesis Announces New PuraPly(R) Antimicrobial Small Size
Devices Surgery Wound Care Product Launch
 HSMN NewsFeed - 14 Feb 2018
Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft(TM)C9T1 Skin Tissue
Devices Wound Care
 HSMN NewsFeed - 2 Feb 2018
FDA Approves AVYCAZ(R) (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Nov 2017
Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board
Devices Personnel
 HSMN NewsFeed - 11 Oct 2017
SutroVax Appoints Veteran Vaccine Experts to Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2017
Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier(R) as a Treatment for Life-Threatening Viruses
Devices FDA
 HSMN NewsFeed - 12 Sep 2017
Cardiome Announces Agreement with Basilea for Distribution of Zevtera(R)/Mabelio(R) (Ceftobiprole) in Europe and Israel
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 2 Aug 2017
Amplyx Pharmaceuticals Raises $67 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Jul 2017
Dr. Moncef Slaoui, former GlaxoSmithKline Chairman of Vaccines, Appointed to SutroVax Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2017
Novoteris, LLC Receives FDA and Health Canada Clearance to Start a Phase 2 Clinical Trial of Its Thiolanox(R) Nitric Oxide for the Treatment of Cystic Fibrosis
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 19 May 2017
Iterum Secures $65 Million in Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Mar 2017
SutroVax Announces Closing of $64M via Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 14 Mar 2017
Pfizer Launches Zavicefta(TM) (ceftazidime-avibactam) in the U.K. and Germany, a New Antibiotic to Treat Complicated Infections Caused by Gram-Negative Bacteria
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 23 Dec 2016
Dipexium and PLx Pharma Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Jun 2016
Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ(R) (ceftazidime and avibactam)
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Jun 2016
Allecra Therapeutics Announces €22 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 May 2016
Amplyx Pharmaceuticals Appoints Paul C. Grint, M.D., to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2016
Kris Peterson to Join Paratek Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2016
FDA Accepts and Grants Priority Review for AVYCAZ(R) (ceftazidime and avibactam) Supplemental New Drug Application (sNDA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 11 Nov 2015
Amplyx Pharmaceuticals Secures $40.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Sep 2015
Vomaris and Metrex(TM) Announce Exclusive Distribution Agreement for Procellera(R) Technology in Long Term Care Market
Devices Wound Care Distribution
 HSMN NewsFeed - 15 Jun 2015
Innocoll AG Announces First Patient Dosed in the Cogenzia COACT-2 Phase 3 Study for the Treatment of Diabetic Foot Infection
Devices Wound Care
 HSMN NewsFeed - 5 Mar 2015
Tetraphase Pharmaceuticals Appoints Maria Stahl as Senior Vice President and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2015
FDA Grants Genentech’s Cobimetinib Priority Review for Use in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Feb 2015
Third Rock Ventures Launches REVOLUTION Medicines with $45 Million Series A to Redesign Evolution’s Products to Treat Serious Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jan 2015
Vomaris and Arthrex announce exclusive global distribution agreement for Procellera(R) Technology
Devices Wound Care Orthopaedic Distribution
 HSMN NewsFeed - 5 Dec 2014
Basilea Announces Launch of Antibiotic Zevtera(R) (ceftobiprole medocaril) in Germany
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 14 Jul 2014
Genentech’s Investigational Medicine Cobimetinib, Used in Combination with Zelboraf(R) (Vemurafenib), Helped People with Advanced Melanoma Live Significantly Longer Without Their Disease Worsening
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2014
Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Apr 2014
Aethlon Medical (AEMD) Note: U.S. Clinical Progression
Devices
 HSMN NewsFeed - 9 Apr 2014
Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2014
Chimerix Appoints Lisa Ricciardi to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Mar 2014
Tetraphase Pharmaceuticals Adds Nancy J. Wysenski to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2014
Genmab Announces Phase III Study of Daratumumab in Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Dec 2013
CytoSorbents Provides Clinical Update on CytoSorb Dosing Study
Devices
 HSMN NewsFeed - 18 Dec 2013
Chimerix Appoints Linda M. Richardson as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2013
CorMedix Announces First Sales of Neutrolin(R) in the European Union
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 4 Dec 2013
The Medicines Company Acquires Rempex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Nov 2013
3-V Biosciences Names Dr. William McCulloch Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2013
Novelos Therapeutics Announces a Restructuring of Its Board of Directors and Additional Changes to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2013
Novelos Appoints Industry Veteran to Lead Strategic Realignment
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Sep 2013
Smith & Nephew releases new DURAFIBER(TM) Ag dressing to address bacterial contamination
Devices Wound Care Product Launch
 HSMN NewsFeed - 13 Sep 2013
Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
Diagnostics Personnel
 HSMN NewsFeed - 28 Aug 2013
Grifols and Aradigm Corporation Complete the Closing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin(R)
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 29 Jul 2013
Novelos Therapeutics Announces Leadership Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2013
3-V Biosciences Completes $20 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 May 2013
Novelos Therapeutics Provides Product Pipeline Update
Biopharmaceuticals
 HSMN NewsFeed - 22 Mar 2013
SciClone Appoints Hong Zhao as Chief Executive Officer, China Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2013
Sobi gains distribution rights for Megace(R), Monopril(R), Cefzil(R); and Duricef(R); from PharmaSwiss
Biopharmaceuticals Distribution
 HSMN NewsFeed - 14 Jan 2013
SciClone Announces Appointment of Simon Li to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2012
Study Finds 78% Drop In Surgical Site Infection With AQUACEL(R) Ag SURGICAL Cover Dressing
Devices Surgery Wound Care
 HSMN NewsFeed - 18 Sep 2012
Sarepta Therapeutics' Lead Therapeutic Drugs for Ebola and Marburg Viruses Receive FDA Fast Track Designation
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Aug 2012
Genmab Enters Worldwide Agreement With Janssen for Daratumumab
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 1 Jun 2012
Aeolus Pharmaceuticals Announces AEOL 10150 Reduces Lung Damage After Neupogen(R) Treatment Following Radiation Exposure
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2012
Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Apr 2012
Pluristem Awarded a $3.1 Million Grant by Israeli Government
Regenerative Medicine
 HSMN NewsFeed - 7 Apr 2012
SciClone Announces Board of Directors and Officer Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Feb 2012
Arno Therapeutics Receives Two Orphan-Drug Designations for AR-42 in Treatment of Central-Nervous-System Tumors
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 20 Feb 2012
Plexxikon Announces European Approval of Zelboraf(R) for the Treatment of Patients With BRAF Mutation-Positive Metastatic Melanoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Dec 2011
Todd R. Nelson Ph.D. Named President & Chief Executive Officer of MP Biomedicals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2011
TOPICA Names Dr. Amir Tavakkol Senior Vice President of Clinical Development and Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2011
NovaBay Pharmaceuticals Spotlights NeutroPhase(R) at the Symposium on Advanced Wound Care (SAWC)
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 31 Aug 2011
NexBio's DAS181 (Fludase(R)*) Improves Symptoms in Four Severely Immunocompromised Patients With Life-Threatening Parainfluenza Pneumonitis
Biopharmaceuticals
 HSMN NewsFeed - 17 Aug 2011
FDA Approves Zelboraf (Vemurafenib) and Companion Diagnostic for BRAF Mutation-Positive Metastatic Melanoma, a Deadly Form of Skin Cancer
Biopharmaceuticals Oncology Personalized Medicine FDA
 HSMN NewsFeed - 18 May 2011
Cook Medical Awarded New Contract with Amerinet, Expanding Antibiotic-Impregnated Catheter Access to 54,000 U.S. Health Care Providers
Devices Group Purchasing
 HSMN NewsFeed - 15 Feb 2011
Aeolus Pharmaceuticals Announces Appointment of Russell L. Skibsted as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Nov 2010
Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2010
Forest Announces FDA Approval of Teflaro(TM) (ceftaroline fosamil) for the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Oct 2010
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
Devices Personnel
 HSMN NewsFeed - 20 Sep 2010
Expanded Line of Antibiotic-Impregnated Catheters from Cook Medical Helps Prevent Potentially Fatal Hospital-Acquired Infections
Devices
 HSMN NewsFeed - 17 Sep 2010
Aradigm Presents Results Supporting Once-Daily Dosing With Its Inhaled Liposomal Ciprofloxacin Formulations at the 2010 European Respiratory Society (ERS) Annual Congress
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 7 Sep 2010
FDA Advisory Committee Recommends Approval of Forest Laboratories' Ceftaroline Fosamil for the Treatment of Community Acquired Bacterial Pneumonia and Complicated Skin and Skin Structure Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Sep 2010
ConvaTec Expands AQUACEL(R) Dressing Product Line With Introduction of New Ribbon Dressing
Devices Wound Care
 HSMN NewsFeed - 18 Aug 2010
Euthymics Bioscience, Inc. Appoints Industry Veterans Dr. Pierre Trân, Joan Manthis and William Pappafotopoulos to Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jun 2010
Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 17 Jun 2010
OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 8 Jun 2010
Salix Pharmaceuticals Announces NDA Submission For XIFAXAN550 For Treatment of Non-Constipation Irritable Bowel Syndrome
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 7 Jun 2010
Derma Sciences Receives CE Mark for ALGICELL(R) Ag
Devices Wound Care Regulatory
 HSMN NewsFeed - 1 Jun 2010
Tetraphase Closes $45 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Apr 2010
Achaogen Completes $56 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Mar 2010
ConvaTec Introduces AQUACEL(R) Ag SURGICAL Cover Dressings With Hydrofiber(R) Technology
Devices Surgery
 HSMN NewsFeed - 24 Mar 2010
FDA Approves XIFAXAN(R) 550 MG Tablets for Reduction in Risk of Overt Hepatic Encephalopathy (HE) Recurrence
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Mar 2010
FDA Accepts Filing of Ondine's Pre-Market Approval (PMA) Application for Periowave(TM) Photodisinfection System
Devices Dental FDA
 HSMN NewsFeed - 23 Feb 2010
FDA Advisory Committee Recommends Approval Of XIFAXAN(R) (rifaximin) Tablets, 550 Mg for Maintenance of Remission of Hepatic Encephalopathy
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Feb 2010
TOPICA Names Mark W. Davis Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2010
Chimerix Names Wendy Painter, M.D., M.P.H., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2010
Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Ofloxacin and Fleroxacin
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Jan 2010
Ondine Files PMA Submission for Periowave(TM) Photodisinfection System
Devices Dental FDA
 HSMN NewsFeed - 30 Dec 2009
FDA Issues Complete Response Letter for Ceftobiprole
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Dec 2009
Forest Laboratories Announces Acquisition of Additional Rights Related to NXL 104, a Novel Broad-Spectrum Beta-Lactamase Inhibitor
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Dec 2009
AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens
Diagnostics FDA
 HSMN NewsFeed - 8 Oct 2009
Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Sep 2009
Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Aug 2009
New Data Demonstrate Magnetic Resonance Safety of AQUACEL(R) Ag Dressing
Devices Wound Care Radiology
 HSMN NewsFeed - 12 Aug 2009
Forest Laboratories and AstraZeneca to Co-Develop and Commercialize a Late Stage Next Generation Anti-Infective
Biopharmaceuticals
 HSMN NewsFeed - 11 Aug 2009
Chimerix Raises $16.1 Million in Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Jul 2009
Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2009
Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye')
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 14 May 2009
ConvaTec Launches New AQUACEL(R) Ag Dressing with Strengthening Fiber
Devices Wound Care
 HSMN NewsFeed - 11 May 2009
Cook Medical Launches Industry-First Pressure Injection Peripherally Inserted Catheter with Antibiotic Protection to Prevent Potentially Fatal Infections
Devices
 HSMN NewsFeed - 5 May 2009
Aethlon Medical Discloses New HIV/AIDS Treatment Data
Devices HIV/AIDS
 HSMN NewsFeed - 5 May 2009
AdvanDx Receives FDA 510(k) Clearance for EK/P. aeruginosa PNA FISH(R)
Diagnostics FDA
 HSMN NewsFeed - 7 Apr 2009
Hospira Launches Piperacillin/Tazobactam for Injection in the UK
Biopharmaceuticals Generics
 HSMN NewsFeed - 24 Mar 2009
FDA Approves New Indication for Wyeth's TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2009
Aethlon Medical Announces Significant Viral Load Reduction in Landmark Medical Device Study to Treat HIV/AIDS
Devices HIV/AIDS
 HSMN NewsFeed - 24 Feb 2009
CHMP delays European Commission decision process to approve ZEVTERA(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Jan 2009
ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
Devices Surgery Wound Care FDA
 HSMN NewsFeed - 5 Dec 2008
FDA Advisory Committee Recommends Approval of Bausch & Lomb Besifloxacin Anti-Infective Eye Drop
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 26 Nov 2008
FDA Issues Complete Response Letter for Ceftobiprole for Treatment of Complicated Skin Infections
Biopharmaceuticals
 HSMN NewsFeed - 21 Nov 2008
Zevtera(TM) (ceftobiprole medocaril), the novel anti-MRSA broad-spectrum antibiotic, receives a positive opinion from the CHMP
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 Oct 2008
Rifaximin Demonstrates Highly Statistically Significant Results in Prevention of Hepatic Encephalopathy in Pivotal Phase 3 Study
Biopharmaceuticals
 HSMN NewsFeed - 1 Oct 2008
Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
Diagnostics FDA
 HSMN NewsFeed - 29 Sep 2008
Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
Diagnostics FDA
 HSMN NewsFeed - 16 Jul 2008
Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
Biopharmaceuticals
 HSMN NewsFeed - 30 Jun 2008
Ceftobiprole, a new anti-MRSA broad-spectrum antibiotic, receives its first marketing authorization by Health Canada
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Jun 2008
ArQule Announces Appointment of Brian Schwartz as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jun 2008
Triathlon Medical Ventures Names New Venture Partner
Venture Capital Personnel
 HSMN NewsFeed - 19 Jun 2008
Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals
 HSMN NewsFeed - 4 Jun 2008
Protez Pharmaceuticals to Be Acquired by Novartis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 May 2008
Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 May 2008
InSite Vision Signs AzaSite(R) Licensing and Distribution Agreement with Essex Bio-Technology for People's Republic of China
Biopharmaceuticals Ophthalmology Distribution
 HSMN NewsFeed - 21 May 2008
Aethlon Medical Announces Cancer Treatment License
Devices Licensing
 HSMN NewsFeed - 20 May 2008
Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Apr 2008
MacroChem Acquires Virium Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Mar 2008
E-Z-EM, Inc. Stockholders Approve Merger Agreement
Biopharmaceuticals Radiology Mergers & Acquisitions
 HSMN NewsFeed - 18 Mar 2008
FDA issues Approvable Letter for ceftobiprole, a new anti-MRSA broad-spectrum antibiotic
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Feb 2008
Oculus Innovative Sciences Announces Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 25 Feb 2008
GPC Biotech Announces Corporate Restructuring and Provides Pipeline Update
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Feb 2008
GE Healthcare Announces First Deployment of ApexPro FH Telemetry System on CARESCAPE Enterprise Access at Memorial Hospital North
Devices Monitoring
 HSMN NewsFeed - 6 Feb 2008
CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters
Biopharmaceuticals Licensing
 HSMN NewsFeed - 30 Jan 2008
Stephen Hill, ArQule President and CEO, to Join Solvay Pharmaceuticals, Inc. as New President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2008
Delcath and Aethlon Medical Sign Collaboration Agreement to Research and Develop Advanced Filtration Technology
Devices Oncology
 HSMN NewsFeed - 22 Jan 2008
The Aethlon Hemopurifier(R) Proves Effective in Capturing Bird Flu Virus
Devices
 HSMN NewsFeed - 22 Jan 2008
Novexel and Forest Laboratories Announce License Agreement for NXL 104, a Novel Broad-Spectrum Beta Lactamase Inhibitor
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Jan 2008
ArQule Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2008
Oculus Innovative Sciences Completes Patient Treatment and Follow-up in Its Phase II Clinical Trial in Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 18 Dec 2007
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Drug Delivery Wound Care
 HSMN NewsFeed - 26 Nov 2007
Bradley Pharmaceuticals Launches ROSULA(R) CLK(TM)
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 19 Nov 2007
The Aethlon Hemopurifier(R) Reverses Immune Suppression in Cancer
Devices Oncology
 HSMN NewsFeed - 15 Nov 2007
PolyMedix Appoints Vice President of Drug Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2007
Aethlon Medical Initiates Human Clinical Studies
Devices
 HSMN NewsFeed - 30 Oct 2007
E-Z-EM to Merge with Bracco Diagnostics in $241 Million Cash Transaction
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 24 Oct 2007
FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
Biopharmaceuticals
 HSMN NewsFeed - 9 Oct 2007
Basilea Announces Positive Top-line Data from Phase III Study of Ceftobiprole in Hospital-Acquired Pneumonia
Biopharmaceuticals
 HSMN NewsFeed - 8 Oct 2007
ArQule Names Peter Lawrence Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2007
HEALTHPOINT Announces Exclusive Distribution Agreement with Hydrofera, LLC
Devices Wound Care Distribution
 HSMN NewsFeed - 12 Sep 2007
OpGen Announces $23.6 Million Series A Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 10 Sep 2007
E-Z-EM Adds EmpowerMR Injector to Amerinet Group Purchasing Contract
Devices Group Purchasing Radiology
 HSMN NewsFeed - 5 Sep 2007
Novation Awards Agreement to E-Z-EM for EDA(TM) Technology for Empower(R) CT Injectors
Devices Radiology Group Purchasing
 HSMN NewsFeed - 5 Sep 2007
Aethlon Medical Initiates Hemopurifier(R) Shipments to India
Devices
 HSMN NewsFeed - 22 Aug 2007
Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
Biopharmaceuticals
 HSMN NewsFeed - 20 Aug 2007
PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 1 Aug 2007
American Academy of Dermatology Says New Technologies Tighten Skin From Head to Toe Without Surgery
Devices Dermatology
 HSMN NewsFeed - 1 Aug 2007
American Academy of Dermatology Says Research Shows Incidence of Melanoma on the Rise
Dermatology Oncology
 HSMN NewsFeed - 19 Jul 2007
NUCRYST Pharmaceuticals receives FDA clearance of antimicrobial barrier topical cream
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jul 2007
Aethlon Medical Announces Cancer Treatment Discovery
Devices Oncology
 HSMN NewsFeed - 6 Jul 2007
Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Biopharmaceuticals
 HSMN NewsFeed - 27 Jun 2007
Aethlon Medical Announces Approval of Clinical Study
Devices
 HSMN NewsFeed - 21 Jun 2007
Arpida Receives Approval From US FDA to Initiate a Phase II Trial With iclaprim in Hospital-Acquired, Ventilator and Healthcare-Associated Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jun 2007
Basilea Announces Submission of Marketing Authorization Application in Europe by Janssen-Cilag International NV for Ceftobiprole, a Novel Anti-MRSA Broad-spectrum Cephalosporin
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Jun 2007
KCI Enters into Exclusive Worldwide License with NovaBay for NeutroPhase(TM) Wound Treatment Solution Technology
Devices Biopharmaceuticals Wound Care Licensing
 HSMN NewsFeed - 30 May 2007
Swiss Regulatory Authority Grants Accelerated Assessment of Planned Market Authorization Application for Ceftobiprole
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 May 2007
New Drug Application Submitted For Novel Investigational Antibiotic Ceftobiprole
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 May 2007
Hercules Provides $10 Million Financing to Early-Stage Neosil, a Pharmaceutical Company Developing Dermatological Treatments
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 4 May 2007
Treatment with COPAXONE(R) Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 May 2007
Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 30 Apr 2007
InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 27 Apr 2007
Inspire Announces FDA Approval Of AzaSite(TM)
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 18 Apr 2007
Carrington and Primus Pharmaceuticals Sign Long-Term Supply and Patent Licensing Agreements for Acemannan Hydrogel(TM)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Mar 2007
Aethlon Medical Files Cancer Treatment Patent
Devices Oncology
 HSMN NewsFeed - 6 Mar 2007
Aethlon Medical Announces FDA Submission
Devices FDA
 HSMN NewsFeed - 19 Feb 2007
Basilea Reports Positive Phase III Results for Alitretinoin
Biopharmaceuticals
 HSMN NewsFeed - 16 Feb 2007
Inspire Licenses AzaSite(TM) For Ocular Infections
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 16 Feb 2007
InSite Vision Announces License Agreement With Inspire Pharmaceuticals
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 15 Feb 2007
InSite Vision Announces Patent Agreement With Pfizer
Biopharmaceuticals Drug Delivery Ophthalmology Licensing
 HSMN NewsFeed - 10 Jan 2007
Basilea Announces Positive Top-Line Results On Second Pivotal Phase III Ceftobiprole Trial
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2007
Provectus Receives Orphan Drug Designation from FDA for Anti-Cancer Agent PV-10 for the Treatment Of Metastatic Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Dec 2006
Basilea Announces Start of Phase III Program for Isavuconazole, Its Third Investigational Drug to Reach Pivotal Trials
Biopharmaceuticals
 HSMN NewsFeed - 15 Dec 2006
Receptor BioLogix Names Four New Senior Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2006
Cerexa to Be Acquired by Forest Laboratories for $480 Million Plus Potential $100 Million Milestone Payment
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Dec 2006
Forest Laboratories Announces Acquisition of Cerexa, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Dec 2006
Basilea to Co-Promote Ceftobiprole
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2006
Indevus and Sanofi-Aventis' Spin-Out Company, Novexel, Announce Out-licensing of Aminocandin Anti-fungal
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Nov 2006
Spectrum Dynamics Receives 510(K) Clearance for the D-SPECT(TM) Cardiac System
Devices Cardiology Radiology FDA
 HSMN NewsFeed - 20 Nov 2006
Eisai Recieves Positive Opinion for Inovelon(R) Marketing Authorization from European Committee for Medicinal Products for Human Use (CHMP)
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 13 Nov 2006
Aethlon Medical Acquires Strategic Cancer Therapy Patent
Devices Oncology
 HSMN NewsFeed - 9 Nov 2006
Innocoll Announces Investigational New Drug Application Filing for its CollaRx GENTAMICIN as a Topical Treatment for Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 13 Oct 2006
Bayer Appoints Independent Investigator to Review Trasylol(R) Study Issues
Biopharmaceuticals
 HSMN NewsFeed - 13 Oct 2006
BioAlliance Pharma Receives Marketing Authorisation for Its First Product, Loramyc(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Oct 2006
Achaogen Closes Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Sep 2006
Bayer Acknowledges That New Trasylol Study Was Not Disclosed Prior to Recent FDA Cardio-Renal Advisory Committee Meeting
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 29 Sep 2006
Efficacy of Once-Daily AVELOX(R) in Treating Complicated Intra-Abdominal Infections Highlighted in Two Clinical Data Presentations at ICAAC
Biopharmaceuticals
 HSMN NewsFeed - 29 Sep 2006
Basilea Reports Excellent Pivotal Data for Ceftobiprole, a Novel Anti-MRSA Broad-spectrum Investigational Antibiotic, at ICAAC
Biopharmaceuticals
 HSMN NewsFeed - 29 Sep 2006
New Data Confirming Broad Spectrum of Basilea's Late-Stage Antifungal, BAL8557, Presented at the ICAAC Conference
Biopharmaceuticals
 HSMN NewsFeed - 21 Sep 2006
FDA Advisory Committee Strongly Endorses Use of Trasylol(R) in CABG Surgery Patients
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 18 Jul 2006
Dr. Harold Handley Appointed President of Aethlon Medical, Inc.
Devices Personnel
 HSMN NewsFeed - 30 Jun 2006
Receptor BioLogix Names Thomas A. Glaze Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2006
InSite Vision Announces Submission of AzaSite(TM) NDA
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 26 Jun 2006
Vasogen Announces Initial Results from Phase III ACCLAIM Trial in Chronic Heart Failure
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 26 May 2006
Lupin Announces Final FDA Approval of Cefdinir Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 May 2006
Acadesine Reduces Two-year Mortality Following Heart Attacks in Heart Bypass Patients
Biopharmaceuticals Cardiology
Return to NewsFeed  

 Additional items found! 154

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 154 additional stories matching:
D-SPECT
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!